Skip to main content

Table 1 Clinicopathological characteristics and expression of miR-216 in studied cervical cancer patients

From: MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis

Factor No. (%)
Age (years)
  ≤ 55 76 50.6
  > 55 74 49.7
FIGO stage
 I/II 51 34
 III/IV 99 66
Histology
 Squamous 121 80.7
 Others 29 19.3
Survival status
 Alive 55 36.7
 Dead 95 63.3
Expression of miR-216
 Low expression 75 50
 High expression 75 50